- Business
- Fosun International Limited is a diversified investment conglomerate headquartered in Shanghai, China, founded in 1992. The company operates across multiple sectors including health, happiness, wealth, and intelligent manufacturing, with an extensive global footprint spanning over 35 countries. Fosun's core products and services encompass healthcare products and pharmaceuticals under Fosun Pharma; tourism and leisure services including the global vacation brand Club Med and new offerings such as Super Resort, Super Resort Complex, and Super Culture and Tourism Mall; financial services with a focus on insurance and investment; and real estate development and management.
In healthcare, Fosun Pharma leads with a broad portfolio of pharmaceuticals, biologics, medical devices, and health management solutions, supported by substantial R&D investments and innovation in drug development. The tourism segment focuses on transforming China's tourism from sightseeing to vacationing, leveraging premium service brands like Club Med to offer diversified cultural and experiential products. Financial services include insurance and asset management, with recent strategic portfolio shifts such as the sale of the Ageas stake, reflecting a recalibration of its insurance business. The real estate division develops integrated urban complexes and operates in key domestic and international markets.
Recent major developments include a strategic cooperation agreement signed in January 2025 with Natixis Corporate & Investment Banking to deepen collaboration in advisory, financing, transaction structuring, and risk hedging to support Fosun's global development. In late 2025, Fosun Tourism Group launched three core product lines—Super Resort, Super Resort Complex, and Super Culture and Tourism Mall—aimed at responding to evolving domestic tourism demands and enhancing vacation experience offerings. The company also reinforced its commitment to innovation and globalization, with 2024 and 2025 seeing increased investment in healthcare R&D and international expansion efforts. These strategic moves underscore Fosun's focus on expanding its ecosystem and driving sustainable growth across its diversified portfolio.
Fosun International targets high-value consumer segments and institutional clients, leveraging its integrated ecosystem approach known as customer-to-maker (C2M), to connect industries and brands. Its operations span Mainland China, Europe, the Americas, and emerging markets, with subsidiaries and affiliates exceeding 300 entities worldwide. Fosun maintains a strong commitment to sustainability and ESG principles, recognized in the S&P Global Sustainability Yearbook 2025 and continually featuring in major ESG indexes.
Overall, Fosun International Limited remains a major investment group with diversified business units focused on delivering quality products and services across healthcare, tourism, financial services, and intelligent manufacturing, supported by recent strategic partnerships and a clear emphasis on innovation and globalization to sustain long-term growth.